Specialist insurance provider CFC is expanding its life sciences insurance solution to accommodate the needs of mid-market companies on a global basis, according to a press release.
CFC will now be able to provide excess products liability, E&O, and clinical trials solutions for global clinical research organisations and companies manufacturing or selling medical devices, functional food and dietary supplements with a revenue threshold of £2.5 billion (around SG$4.5 billion). The provider can also offer limits up to £10 million (around SG$18 million).
You’ve reached your limit – Register for free now for unlimited access
To read the full story, and get unlimited access to Insurance Business website content, just register for free now. GET STARTED HERE
Already a website member? Log in below.